1. Home
  2. CMPS vs IPI Comparison

CMPS vs IPI Comparison

Compare CMPS & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • IPI
  • Stock Information
  • Founded
  • CMPS 2020
  • IPI 2000
  • Country
  • CMPS United Kingdom
  • IPI United States
  • Employees
  • CMPS N/A
  • IPI N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • CMPS Health Care
  • IPI Industrials
  • Exchange
  • CMPS Nasdaq
  • IPI Nasdaq
  • Market Cap
  • CMPS 364.9M
  • IPI 475.8M
  • IPO Year
  • CMPS 2020
  • IPI 2008
  • Fundamental
  • Price
  • CMPS $3.68
  • IPI $35.05
  • Analyst Decision
  • CMPS Strong Buy
  • IPI Strong Sell
  • Analyst Count
  • CMPS 7
  • IPI 1
  • Target Price
  • CMPS $17.83
  • IPI $19.00
  • AVG Volume (30 Days)
  • CMPS 5.0M
  • IPI 144.2K
  • Earning Date
  • CMPS 07-31-2025
  • IPI 08-04-2025
  • Dividend Yield
  • CMPS N/A
  • IPI N/A
  • EPS Growth
  • CMPS N/A
  • IPI N/A
  • EPS
  • CMPS N/A
  • IPI N/A
  • Revenue
  • CMPS N/A
  • IPI $217,865,000.00
  • Revenue This Year
  • CMPS N/A
  • IPI $11.06
  • Revenue Next Year
  • CMPS N/A
  • IPI N/A
  • P/E Ratio
  • CMPS N/A
  • IPI N/A
  • Revenue Growth
  • CMPS N/A
  • IPI N/A
  • 52 Week Low
  • CMPS $2.25
  • IPI $20.75
  • 52 Week High
  • CMPS $8.54
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 50.85
  • IPI 42.90
  • Support Level
  • CMPS $2.25
  • IPI $35.84
  • Resistance Level
  • CMPS $3.50
  • IPI $37.84
  • Average True Range (ATR)
  • CMPS 0.31
  • IPI 1.20
  • MACD
  • CMPS 0.07
  • IPI -0.12
  • Stochastic Oscillator
  • CMPS 87.42
  • IPI 23.35

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: